This inventor holds 9 USPTO granted patents and 15 published patent applications. Top assignees: Beijing University of Technology, Puretech Lyt, Inc., Seaport Therapeutics, Inc.. Active years: 2000-2026.
Location History:
- Brooklet, GA (US) (2000)
- Doylestown, PA (US) (2014)
- Sharon, MA (US) (2022 - 2024)
Company Filing History:
6 out of 387 
5 out of 7 
2 out of 2 Years Active: 2000-2026
Title: The Innovative Contributions of Daniel Kenneth Bonner
Introduction
Daniel Kenneth Bonner is a prominent inventor based in Sharon, MA, known for his significant contributions to pharmaceutical innovations. With a total of eight patents to his name, Bonner's work focuses on the development of advanced lipid prodrugs aimed at improving drug delivery and therapeutic efficacy.
Latest Patents
Among his latest innovations, Bonner has patented two significant inventions related to lymphatic system-directing lipid prodrugs. The first patent details a method for producing lipid prodrugs and pharmaceutical compositions that enhance the bioavailability of therapeutic agents. This innovation is crucial for treating various diseases, disorders, or conditions, providing improved treatment options for patients in need. The second patent offers similar advancements but focuses specifically on lipid prodrugs of neurosteroids, again emphasizing the methods of improving a therapeutic agent’s properties for better medical outcomes.
Career Highlights
Throughout his career, Bonner has been associated with reputable institutions, including the Beijing University of Technology and Puretech Lyt, Inc. His work at these organizations has furthered research in pharmacology and drug delivery systems. Bonner's innovative mindset and dedication to advancing medical science have earned him recognition in the field.
Collaborations
In his journey as an inventor, Daniel Kenneth Bonner has collaborated with talented professionals like Rishab R Shyam and Jamie Simpson. These collaborations have contributed to the refinement of his inventions and have played a pivotal role in the success of his patent applications.
Conclusion
Daniel Kenneth Bonner's innovations in lipid prodrugs represent significant advancements in the pharmaceutical industry. His commitment to improving treatment options for patients through research and development showcases the vital role of inventors in shaping the future of medicine. With his impressive portfolio of patents, Bonner continues to pave the way for innovative solutions in healthcare.